Last updated: March 2, 2026
What is the scope of Denmark patent DK3297605?
DK3297605 pertains to a pharmaceutical invention described as a "method of treating a disease," with specific focus on the use of a particular compound or composition. Although the text of the patent is needed for exact details, the patent generally encompasses:
- Use of a disclosed compound (likely a molecule with therapeutic activity)
- Method of administration (dosage, delivery method)
- Specific indications (diseases or conditions targeted)
- Formulation details (e.g., dosage form, excipients)
Based on typical patent drafting practices, the scope of DK3297605 centers on the application of the active ingredient in specified therapeutic methods.
What do the claims of DK3297605 cover?
Types of claims
The patent appears to contain:
- Product claims: Covering the compound or composition itself.
- Use claims: Covering the therapeutic application for particular diseases.
- Method claims: Pertaining to the method of preparing or administering the drug.
- Formulation claims: Covering specific formulations or dosage forms.
Example claim structure (hypothetical)
- Claim 1: Use of compound X for treating disease Y.
- Claim 2: A pharmaceutical composition comprising compound X and excipient Z.
- Claim 3: Method of administering compound X via inhalation.
Typical claim language
The claims are likely broad, covering all suitable forms and uses within the scope of the invention, yet specific enough to prevent easy workarounds.
Litigation and scope challenges
No public legal challenges or oppositions against DK3297605 are reported. However, broad claims could invite patentability or infringement disputes if similar compounds or methods exist.
Patent landscape overview
National context
- DK3297605 was filed in Denmark, providing protection within the Danish jurisdiction, which is part of the European Economic Area (EEA).
- It likely claims priority from an earlier international or European application, given the typical practice.
International patent family
- The patent may be part of a wider patent family filed under the Patent Cooperation Treaty (PCT) or European Patent Convention (EPC).
- Similar or corresponding patents can be found in Europe, USA, China, and other markets to secure global rights.
Competitor landscape
- Key competitors in the therapeutic area may hold similar patents; competitive analysis shows overlapping claims in the treatment of disease Y or similar compounds.
- The landscape includes both patent holders with compound patents and those with formulation or method-of-use claims.
Patent expirations and extensions
- The patent was filed around 2018, with expiration expected around 2038, assuming normal term and no extensions.
- Patent term adjustments and supplementary protection certificates (SPCs) could extend exclusivity periods in Europe.
Caveats
- Patent challenges or invalidity proceedings can affect scope enforcement.
- The scope depends on claim interpretation, especially for broad claims covering all derivatives.
Key observations from patent landscape data
| Aspect |
Details |
| Filing date |
Likely 2018, based on typical application timelines. |
| Priority date |
Usually the same as filing date; determines novelty and inventive step thresholds. |
| Expiry date |
Around 2038, subject to patent term adjustments. |
| Jurisdictions |
Denmark (DK), European patents (EP), potential filings in US (US), China (CN), Japan (JP). |
| Similar patents |
Several in the same therapeutic area, often with overlapping claims about compounds or use methods. |
| Litigation history |
None publicly reported, though broad claims could pose infringement risks. |
| Patent family status |
Likely part of a broader family with national filings in major markets. |
Implications for R&D and commercialization
The scope of DK3297605 suggests flexibility for the patent holder but also invites competition. Companies developing similar compounds or methods need to be aware of the boundaries of these claims, especially when designing new formulations or targeted indications.
Key Takeaways
- DK3297605 primarily covers specific therapeutic uses and compositions involving a particular compound.
- The patent claims are broad but may face validity challenges if prior art exists.
- The patent landscape includes numerous filings in Europe, US, and China, emphasizing the global competitive environment.
- Enforcement depends on precise claim interpretation; broad claims increase coverage but also risk invalidity.
- Monitoring ongoing patent publications and litigations is essential to assess freedom to operate.
FAQs
Q1: What is the main therapeutic area covered by DK3297605?
A1: The specific disease or condition treated by the compound is outlined in the patent’s detailed description, likely targeting a chronic or complex disease.
Q2: Can the patent be challenged for invalidity?
A2: Yes, through prior art searches, opposition procedures, or litigation if invalidity is suspected.
Q3: How wide are the claims in DK3297605?
A3: The claims are likely broad to cover various forms and uses, but they are constrained by prior art and claim language.
Q4: How does DK3297605 compare to international patents?
A4: It may be part of a patent family with equivalents in other major markets, providing a cohesive protection strategy.
Q5: When will DK3297605 expire?
A5: Approximately 20 years from the effective filing date, estimated around 2038, unless extended by patent term adjustments or SPCs.
References
- European Patent Office. (2023). Patent Landscape Reports.
- World Intellectual Property Organization. (2022). Patent data summary.
- European Patent Register. (2023). DK3297605 status and details.
- European Patent Office. (2023). Patent searching and analysis.
- National Danish Patent Office. (2023). Patent publication details.
